Sermorelin: the compounded peptide you can actually name

Clinic owners ask me about a long list of peptides. My honest answer is usually “be careful how you talk about that one” — with a real exception. Sermorelin sits on firmer ground than the rest, and it’s worth understanding why.

By Aleah Evans · August 15, 2026

“Which peptide?” is really a regulatory question

When a clinic asks me “can we offer peptide X?”, the honest answer almost never turns on the science — it turns on the substance’s regulatory status. Compounding pharmacies can only work from bulk substances that sit inside a specific, defined lane: the ingredient has to be a component of an approved drug, appear on a federal pharmacopoeia, or clear the FDA’s bulk-substance review.³ A lot of the trendy peptide names don’t clear that bar today — the widely-shared “they were just approved” claims from early 2026 referred to withdrawn nominations, not clearances. So the careful move is to talk about categories, not to advertise a menu of named molecules the pathway doesn’t actually support.

What makes sermorelin different

Sermorelin has a history the others don’t. It was the active ingredient in GEREF, a drug the FDA approved decades ago. GEREF was later discontinued — but here’s the part that matters: when the FDA reviewed it, the agency formally determined the product was not withdrawn from sale for reasons of safety or effectiveness.¹ In plain terms, it left the market for business reasons, not because regulators found it unsafe or ineffective.

That determination is quietly important. Being a component of a once-approved drug that wasn’t pulled for safety or efficacy is exactly the kind of status that gives a substance a defensible footing in the 503A compounding framework — the footing most of the peptide list simply doesn’t have. It’s why, of everything clinics ask about, sermorelin is the one I’ll name plainly.

What it is, in plain terms

Sermorelin is a growth-hormone-releasing hormone analog — a prescription compounded preparation used under a provider’s direction. I’m deliberately not going to make efficacy or outcome promises here; that’s a clinical conversation between a patient and their prescriber, and it’s not mine (or any marketer’s) to make. What I can tell you is the category it belongs to and the regulatory footing it stands on — which is the part clinics actually need from me.

What this means for your practice

If your practice is building peptide or wellness services and wants a substance you can discuss openly, source through a prescriber-gated account, and stand behind, sermorelin is a sensible starting point. The same rules still apply: it’s a prescription product, so your practice needs a licensed provider on file, and it’s dispensed from licensed 503A or 503B pharmacies. None of that changes. What changes is your confidence that you’re naming something on solid ground.

The honest caveats

• Compounded is not FDA-approved. An individual compounded sermorelin preparation is not an FDA-approved drug; it’s prepared by a licensed pharmacy under FDA oversight of compounding operations. That framework is legitimate — and it’s a different thing from an approved, mass-manufactured product.
• The rest of the menu doesn’t share this footing. Sermorelin’s clean status is specific to sermorelin. It doesn’t extend to the other peptides that get marketed alongside it, and treating it as if it does is how practices drift into trouble.
• It’s still provider-directed. Whether sermorelin is appropriate for any patient is a clinical judgment, made after evaluation — never a marketing claim.

Where I fit

This is the kind of distinction I think a good rep should be able to explain — not to impress you, but so you can make decisions without having to become a compounding-law expert yourself. If you want to talk through where sermorelin (or the broader category) fits your practice, that’s exactly the conversation I’m here for.

Educational only — general regulatory framework, not legal or medical advice, and not specific to any one product. Compounded preparations are not FDA-approved drugs. Ready when you are? You can start a Blue Atlas application — a practice that applies through my link is credited to me.